Loading…

Ameliorative effect of mangiferin on high fat diet - Diethylnitrosamine induced non-alcoholic steatohepatitis rats

Non-alcoholic steatohepatitis (NASH) is a serious form of nonalcoholic fatty liver disease (NAFLD) which leads to fibrosis, cirrhosis and liver failure. This study is aimed to investigate the therapeutic effect of mangiferin, a major glucoxanthone of Mangifera indica L., on NASH. Pharmacokinetic pro...

Full description

Saved in:
Bibliographic Details
Published in:Biocatalysis and agricultural biotechnology 2022-05, Vol.41, p.102312, Article 102312
Main Authors: Nagul Kumar, Sanmugapriya, Darvin, Santhaanam Sylvester, Toppo, Erenius, Porchezhian, Vedapuri, Pandikumar, Perumal, Paulraj, Michael Gabriel, Ignacimuthu, Savarimuthu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-alcoholic steatohepatitis (NASH) is a serious form of nonalcoholic fatty liver disease (NAFLD) which leads to fibrosis, cirrhosis and liver failure. This study is aimed to investigate the therapeutic effect of mangiferin, a major glucoxanthone of Mangifera indica L., on NASH. Pharmacokinetic property of mangiferin was assessed using DataWarrior tool and the compound was docked with PPARα protein using Autodock tool. Anti-NASH efficacy of mangiferin was assessed in HFD-DEN induced Wistar rats at 50 and 100 mg/kg b. w. concentrations. Treatment with mangiferin significantly lowered plasma and liver lipid levels; it also reduced transaminase levels. The ultrasonography and histopathological studies showed reduction of steatosis and inflammation in the liver with mangiferin treatment. The treatment increased the hepatic mRNA expressions of PPARα and FXR. These preliminary evidences gave an insight on the anti-NASH potential of mangiferin; further intensive studies are needed to establish it. [Display omitted] •Mangiferin was isolated from Mangifera indica.•Mangiferin reduced the liver damage in HFD-DEN fed rats at 50 and 100 mg/kg b. w.•Mangiferin upregulated the PPARα expression in HFD-DEN fed rats.•Mangiferin bound to a new conservative target in PPARα protein with less energy.
ISSN:1878-8181
1878-8181
DOI:10.1016/j.bcab.2022.102312